Literature DB >> 6197369

Identification of the MT3 molecule using two-dimensional gel electrophoresis and alloantisera.

M Suzuki, H Maeda, R Mukai, T Yabe, H Hamaguchi.   

Abstract

The MT3 antigen is defined serologically as a DR supertypic specificity and is strongly associated with DR4, DR7, and DRw9. To determine whether the MT3 molecule is distinct from the DR molecule, DR4 and MT3 antigens were immunoprecipitated from 125I-labeled plasma membrane glycoproteins of a DR4-homozygous, MT3-homozygous B lymphoid cell line, Wa, and compared by two-dimensional (2-D) gel electrophoresis. The precipitates with two different anti-DR4 alloantisera and with three different mouse antibodies against human Ia monomorphic determinants gave the same 2-D gel pattern consisting of one heavy chain with a molecular weight of 34 000 and a set of light chains with a molecular weight of 30 000, indicating that these polypeptides are the components of the DR4 molecule. On the other hand, all three anti-MT3 alloantisera used precipitated an identical set of anti-MT3 alloantisera specific light chains with a molecular weight of 30 000, and one heavy chain with a molecular weight of 34 000. The pI of the MT3 light chain was more acidic than that of the DR4 light chain. The amount of MT3 light chains was much smaller than that of DR4 light chains in unlabeled plasma membrane glycoproteins. Thus, we have demonstrated directly using 2-D gel electrophoresis and anti-MT3 alloantisera that the MT3 antigen is a new human Ia molecule distinct from DR4.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6197369     DOI: 10.1007/BF00345965

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   3.330


  19 in total

1.  Organization of the immune response genes.

Authors:  J W Uhr; J D Capra; E S Vitetta; R G Cook
Journal:  Science       Date:  1979-10-19       Impact factor: 47.728

2.  Alloantigens of human lymphoid cell lines; 'human Ia-like antigens'. Alloantigenic activity and cell line, organ and tissue distribution as determined by radioimmunoassay.

Authors:  K Koyama; K Nakamuro; N Tanigaki; D Pressman
Journal:  Immunology       Date:  1977-08       Impact factor: 7.397

3.  Glycoproteins of Ehrlich asctes carcinoma cells. Separation of plasma and endoplasmic reticular membrane fragments.

Authors:  J Molnar; G Markovic; H Chao; Z Molnar
Journal:  Arch Biochem Biophys       Date:  1969-11       Impact factor: 4.013

4.  Biosynthesis and maturation of HLA-DR antigens in vivo.

Authors:  M J Owen; A M Kissonerghis; H F Lodish; M J Crumpton
Journal:  J Biol Chem       Date:  1981-09-10       Impact factor: 5.157

5.  Family studies define a new histocompatibility locus, SB, between HLA-DR and GLO.

Authors:  S Shaw; P Kavathas; M S Pollack; D Charmot; C Mawas
Journal:  Nature       Date:  1981-10-29       Impact factor: 49.962

6.  Two populations of Ia-like molecules on a human B cell line.

Authors:  L A Lampson; R Levy
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

7.  Murine Ia and human DR antigens: homology of amino-terminal sequences.

Authors:  J P Allison; L E Walker; W A Russell; M A Pellegrino; S Ferrone; R A Reisfeld; J A Frelinger; J Silver
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

8.  Ia determinants on human T-cell subsets defined by monoclonal antibody. Activation stimuli required for expression.

Authors:  E L Reinherz; P C Kung; J M Pesando; J Ritz; G Goldstein; S F Schlossman
Journal:  J Exp Med       Date:  1979-12-01       Impact factor: 14.307

9.  A homozygous human cell line contains three subsets of HLA-DR-like antigens distinguishable by amino acid sequencing.

Authors:  D W Andrews; M R Bono; J L Strominger
Journal:  Biochemistry       Date:  1982-12-21       Impact factor: 3.162

10.  Demonstration of a third structurally distinct human Ia beta chain by two-dimensional gel electrophoresis.

Authors:  R W Karr; C C Kannapell; J A Stein; T C Fuller; R J Duquesnoy; G E Rodey; D L Mann; H M Gebel; B D Schwartz
Journal:  J Exp Med       Date:  1982-08-01       Impact factor: 14.307

View more
  4 in total

1.  Correlation between an HLA-DQ alpha length polymorphism of messenger RNA and serologically defined specificities (DQw1, DRw53, DR3+5).

Authors:  P Loiseau; P Lehn; F Dautry; V Lepage; J Colombani; D Cohen; J Dausset; L Degos
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

2.  The MT3 specificity resides on a novel human class II antigen distinct from the HLA-DR antigen and DC-like antigen.

Authors:  T Yabe; M Suzuki; M Satake; T Juji; H Hamaguchi
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

3.  Autoantibodies to T and B cell lines detected in serum samples from patients with systemic lupus erythematosus with lymphopenia and hypocomplementaemia.

Authors:  M Noguchi; M Iwamori; T Hirano; S Kobayashi; H Hashimoto; S Hirose; Y Nagai
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

4.  Two-dimensional gel electrophoretic analysis of the MT3 and DR4 molecules from the different D-typed cells.

Authors:  M Suzuki; T Yabe; M Satake; T Juji; H Hamaguchi
Journal:  J Exp Med       Date:  1984-09-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.